Related Experiment Videos
[Antihypertensive therapy and heart diseases]
1Second Department of Medicine, Kyoto Prefectural University of Medicine.
Insights
Antihypertensive therapy, particularly ACE inhibitors, effectively reverses cardiac hypertrophy and improves heart function in hypertensive patients. These treatments reduce cardiovascular event risks by enhancing coronary flow and nitric oxide release.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Research
Context:
- Hypertensive heart disease, including cardiac hypertrophy and ischemic conditions, poses significant cardiovascular risks.
- Antihypertensive therapy aims to prevent and manage these complications, with regression of cardiac hypertrophy being a key goal.
- Impaired nitric oxide (NO) release in coronary arteries is a characteristic of hypertension.
Purpose:
- To evaluate the efficacy of antihypertensive agents in managing hypertensive heart disease.
- To assess the role of Angiotensin-Converting Enzyme inhibitors (ACEI) in regressing cardiac hypertrophy.
- To investigate the impact of antihypertensive drugs on coronary microvascular function and NO bioavailability.
Summary:
- ACE inhibitors demonstrate potent effects in regressing cardiac hypertrophy, thereby reducing cardiovascular event risk.
- Both ACE inhibitors and calcium channel blockers improve coronary flow reserve, particularly in microvascular circulation.
- Clinical evidence, such as the "TREND" study, supports ACE inhibitors' ability to restore reduced nitric oxide release in hypertensive patients.
- ACE inhibitors are effective for heart failure, with calcium antagonists and beta-blockers also showing positive outcomes.
Impact:
- Effective management of hypertensive heart disease through targeted pharmacotherapy can significantly lower morbidity and mortality.
- Understanding the mechanisms by which antihypertensives improve cardiac function aids in personalized treatment strategies.
- The findings support the use of ACE inhibitors as a cornerstone therapy for hypertensive cardiovascular complications.
Abstract:
The one of the most important goal of antihypertensive therapy is to prevent and improve the hypertensive heart disease including cardiac hypertrophy and ischemic heart disease. The regression of cardiac hypertrophy by treatment reduce the risk of cardiovascular events. ACE inhibitor (ACEI) may be the most powerful among antihypertensive agents to regress hypertrophy. Ca-antagonist and ACEI can improve the impaired coronary flow reserve by microvascular circulation. Recently, the evidences have been accumulated that the release of nitric oxide (NO) from the coronary artery of hypertension is reduced. "TREND" study proved that ACEI can improve this decreases in the clinical study. For the heart failure, ACEI is a effective drugs, and Ca-antagonist and beta-blocker also have been getting good results.